
The value of diagnostics in the fight against antimicrobial resistance – by Rosanna W. Peeling, David L. Heymann & Debi Boeras
more
Sulbactam plus durlobactam: a new addition to antibacterial therapies – by Ursula Theuretzbacher
more
The end of the pipeline is dry: major gaps in the clinical evidence required to inform clinical and country-level appraisal and use of newly ...
more
Plasmid-mediated resistance in the gonococcus and the use of post-exposure prophylaxis to prevent bacterial STIs – by Christoph M. Tang, ...
more
Nonclinical evidence for drug effectiveness can support streamlined antibacterial drug development – by Tina Guina and Edward A. Weinstein ...
more
Putting the Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act under the microscope – by Jacob Madden, Timo ...
more
The emerging field of digital antibiotic discovery – by Shuangzhe Lin & César de la Fuente
more